GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » 5-Day RSI

RADLY (Raia Drogasil) 5-Day RSI : 45.42 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-12-14), Raia Drogasil's 5-Day RSI is 45.42.

The industry rank for Raia Drogasil's 5-Day RSI or its related term are showing as below:

RADLY's 5-Day RSI is ranked better than
80.14% of 705 companies
in the Healthcare Providers & Services industry
Industry Median: 45.91 vs RADLY: 45.42

Competitive Comparison of Raia Drogasil's 5-Day RSI

For the Pharmaceutical Retailers subindustry, Raia Drogasil's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's 5-Day RSI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's 5-Day RSI falls into.



Raia Drogasil  (OTCPK:RADLY) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (OTCPK:RADLY) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Raia Drogasil 5-Day RSI Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's 5-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil Headlines

From GuruFocus

Q3 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Raia Drogasil S/A Earnings Call Transcript

By GuruFocus News 11-07-2024

Q4 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024